Description: Learn from panelists from different companies as they come together to discuss their experiences.

Description: Indexed universal life (IUL) continues to be the most popular universal life (UL) product with sales reaching $1B in Q4 2023, according to LIMRA. There is little long term experience for IUL and many companies value and model IUL just like UL, but there are material potential differences that need to be considered for valuation and projection purposes. Presenters will discuss key risks and differences between IUL and UL relating to policyholder behavior and how to value, project, monitor and manage those risks to avoid repeating misestimates of the past. Presenters will also discuss broader life assumption risks such as mortality and yearly renewable term (YRT) reinsurance risk. Attendees will learn about options on how to potentially address underperforming blocks of IUL and will obtain an improved perspective on the risks of IUL products and the differences versus UL and how to incorporate these differences into their valuation and projection exercises.

Description: Hear about the latest trends and insights in regard to recent developments in the Life Insurance market. The speakers will discuss changes to the valuation, new business, and product development landscape in light of the recent economic environment, regulatory changes, and the evolution of underwriting practices. Attendees will learn about how pricing, valuation, and forecasting practices are adapting to meet objectives.

Description: Mortality improvement assumptions have typically been focused on all-cause mortality improvement. However, as evidenced in recent years, the cause of death has a large impact on mortality improvement. Join our panel of experts as they discuss mortality improvement through the lens of different causes of death. This discussion will include a review of the historical cause specific mortality improvement trends seen in the U.S. population and how this relates to the insured population. The panelists will then discuss how to use these trends to inform future mortality improvement assumptions. Key learning objectives include: - Identifying the trends in mortality improvement for select causes of death - Understanding how to adapt these for an insured population - Applying these learnings to mortality improvement assumptions

Description: Much has been published about the increased financial statement volatility under U.S. GAAP Long Duration Targeted Improvements (LDTI). Discover more about tools and techniques that actuaries and other financial reporting professionals can use to reduce volatility risk and understand the relationships between certain risks and volatility. By attending the session, you will learn to identify sources of financial statement volatility under LDTI and methods to manage or reduce the volatility.

Description: Go over how the actuarial processes have changed over the past 10+ years with the move to PBR, US GAAP LDTI, IFRS 17 and other emerging requirements.

Description: The qualification of life insurance under Sections 7702 and 7702A can often be complex and result in inadvertent instance of noncompliance for life insurance companies. This session with explore the complexities of product tax compliance from a due diligence perspective as well as discuss other alternatives companies may have as they administer reductions in benefit under Section 7702A.

Description: This session will showcase how from an actuarial perspective IFRS17 has its roots in market consistent valuations. It will also show how International Financial Reporting Standard (IFRS) 17 is rooted in probability-weighted stochastic scenarios-same as fair valuation, and how initial recognition sets the stage, as in the pricing basis and report, for actual experience to emerge as in the subsequent recognition. A detailed model will be given for a simple annual premium non-par endowment and actual numbers given and explained. The stochastic model will explain in detail the key reserve items in IFRS 17 including: - Liability for remaining coverage (LRC) - Risk Adjustment (RA) - Contractual Service Margin (CSM) And it will explain their interactions with one another. A discussion will be held regarding universal life policies with simple interest guarantees. And how these guarantees merit a valuation similar to Lookback options because of their path-dependent nature.

Description: Recently, life insurers have seen a lot of change in their business model. Whether it be new accounting rules (e.g., long-duration targeted improvements [LDTI]) or new capital charges (e.g., structured equity tranche), companies are being forced to reconsider how they invest their assets. Today's session will help attendees understand how companies are using modelling software to help understand the impact of these changes on both their existing portfolio and potential changes that these new regulations may lead to. By attending, attendees will get a better understanding of: - How life insurers' asset allocation decisions are different than other financial companies (e.g., banks, pension funds, P&C companies) - How these changes may impact the risk vs. reward tradeoffs that life insurers' face - How these companies can use modelling software to help evaluate these potential impacts

Description: The session will use a case study to discuss some of the nuances and general considerations for an MRB, FAS 133 and VOBA balances for a business combination for an fixed index annuity (FIA) contract. The case study will discuss some MRB fair value considerations and followed by FAS 133 fair value techniques.